Skip to main content

Saturn Medic

Clinical Subject Page

Upper Tract Urothelial Carcinoma (UTUC)

Upper Tract Urothelial Carcinoma (UTUC) is a malignant tumor arising from the urothelial lining of the upper urinary tract, including the renal pelvis and ureter. It is less common than bladder cancer but can be aggressive, particularly when invasive.

Also called

Upper urinary tract urothelial carcinoma

ICD-10

C65 + C66

Specialty

Urology

Onset

Chronic

Reviewed

August 2026
On This Page

Overview

–Upper Tract Urothelial Carcinoma (UTUC) develops from urothelial cells lining the renal pelvis and ureter. It is broadly assessed according to tumor grade, depth of invasion, location, and metastatic spread.

Clinically, UTUC may be categorized as:

  • Low-risk disease: more likely to be localized and suitable for kidney-sparing treatment in selected patients.

 

  • High-risk disease: associated with invasive disease and often requires radical treatment.

Etiology & Risk Factors

-Etiology

–Upper Tract Urothelial Carcinoma (UTUC) develops through genetic and molecular abnormalities within urothelial cells. Prolonged exposure of the urothelium to carcinogens contributes to malignant transformation.

 

-Risk Factors

  • Cigarette smoking
  • Occupational exposure to certain chemicals
  • Increasing age
  • Previous or concurrent bladder cancer
  • Lynch syndrome
  • Exposure to aristolochic acid

Pathophysiology

Exposure to carcinogens and genetic abnormalities → urothelial DNA damage → accumulation of mutations → uncontrolled urothelial cell proliferation → tumor formation in the renal pelvis or ureter → local invasion → lymphatic and hematogenous spread

Clinical Presentation

-Symptoms:

  • Visible or microscopic hematuria
  • Flank pain
  • Flank mass, rarely
  • Dysuria
  • Urinary frequency
  • Recurrent Urinary Tract Infection (UTI)

Flank pain may occur when the tumor obstructs the ureter and causes hydronephrosis.

 

-Signs:

  • Early disease may have no specific physical findings.

    Advanced disease may cause:

    • Flank mass
    • Weight loss
    • Peripheral edema
    • Lymphadenopathy
Upper Tract Urothelial Carcinoma (UTUC) Overview
Upper Tract Urothelial Carcinoma (UTUC) Overview

History Taking

-Ask about:

  • Visible or microscopic hematuria
  • Flank pain
  • Previous bladder cancer
  • Dysuria or lower urinary tract symptoms
  • Smoking history
  • Occupational chemical exposure
  • Family history of Lynch syndrome
  • Previous urinary tract tumors
  • Recurrent UTI
  • Weight loss

Physical Examination

-General Examination

  • Assess general condition
  • Look for weight loss
  • Check for peripheral edema
  • Assess for lymphadenopathy when advanced disease is suspected

 

-System-Specific Examination:

  • Examine the abdomen and flanks for masses
  • Assess for flank tenderness
  • Look for signs of urinary obstruction

Investigations

-Biochemistry / Specific Tests

  • Urinalysis

  • Urine culture when infection is suspected

  • Serum creatinine and estimated Glomerular Filtration Rate (eGFR)

  • Urine cytology, particularly for suspected high-grade disease

 

-Imaging

Computed Tomography Urography (CT Urography)

The main imaging investigation for suspected Upper Tract Urothelial Carcinoma (UTUC).

It can assess:

  • Tumor location

  • Filling defects

  • Ureteric obstruction

  • Hydronephrosis

  • Regional lymph nodes

  • Other urinary tract abnormalities

 

-Special / Confirmatory Tests

Diagnostic Ureteroscopy

Allows direct visualization of suspicious lesions.

Ureteroscopic Biopsy

May provide tissue for histological confirmation and tumor grading.

Cystoscopy

Should be performed to evaluate the bladder because synchronous bladder tumors may occur.

Diagnosis

-Upper Tract Urothelial Carcinoma (UTUC) is assessed through:

Hematuria or suspicious symptoms → CT urography → cystoscopy to evaluate the bladder → diagnostic ureteroscopy ± biopsy when required → risk and stage assessment → definitive treatment planning.

Home / Home / Clinical Cases / Urology System Clinical Cases / Upper Tract Urothelial Carcinoma (UTUC)
Related Topics

Management

1. Definitive Treatment

Treatment depends on risk classification, tumor location, kidney function, and patient factors.

Low-Risk UTUC

Kidney-sparing treatment may be appropriate in selected patients:

  • Endoscopic tumor ablation

  • Segmental ureterectomy in selected cases

High-Risk UTUC

Radical nephroureterectomy with removal of a cuff of bladder is the standard treatment for many patients with high-risk localized disease.

 

2. Medical Treatment

Systemic therapy may be used:

  • Before surgery in selected high-risk patients

  • After surgery in appropriate patients

  • For locally advanced or metastatic disease

Treatment may include platinum-based chemotherapy and other systemic therapies depending on disease characteristics.

 

3. Surgical / Procedural Treatment

  • Endoscopic tumor ablation

  • Segmental ureterectomy

  • Radical nephroureterectomy

  • Bladder cuff excision

 

4. Supportive Management

  • Monitor renal function

  • Smoking cessation

  • Manage urinary obstruction

  • Treat infection

  • Regular cystoscopic surveillance

Complications

  • Ureteric obstruction
  • Hydronephrosis
  • Kidney dysfunction
  • Local tumor invasion
  • Lymph node metastases
  • Distant metastases
  • Bladder tumor recurrence
  • Contralateral upper urinary tract recurrence

Prognosis

The prognosis of Upper Tract Urothelial Carcinoma (UTUC) depends mainly on tumor stage, grade, depth of invasion, lymph node involvement, metastatic spread, and whether complete tumor removal is possible. Low-grade localized disease generally has a better prognosis, while invasive or metastatic disease carries a less favorable outcome.

Key Points / Clinical Pearls

  • Upper Tract Urothelial Carcinoma (UTUC) arises in the renal pelvis or ureter.
  • Most cases are urothelial carcinomas.
  • Hematuria is the most common presentation.
  • Flank pain may indicate ureteric obstruction.
  • Smoking is an important risk factor.
  • Lynch syndrome increases the risk of UTUC.
  • Previous bladder cancer is an important clinical risk factor.
  • CT urography is the main imaging investigation.
  • Cystoscopy is important because bladder tumors may coexist.
  • Ureteroscopy can directly visualize the lesion.
  • Biopsy helps with diagnosis and risk assessment.
  • Selected low-risk tumors can be treated with kidney-sparing approaches.
  • Radical nephroureterectomy is standard treatment for many high-risk tumors.